NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
11. Januar 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference
16. Dezember 2021 07:00 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Third Quarter 2021 Financial Results
10. November 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy
10. November 2021 16:02 ET
|
NeuroPace, Inc.
IDE study will be first to evaluate the effectiveness of brain-responsive neuromodulation to treat primary generalized epilepsy in patients aged 12 and older MOUNTAIN VIEW, Calif., Nov. 10, 2021 ...
NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021
20. Oktober 2021 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Announces Addition of Lisa Andrade to the Board
19. Oktober 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc., (Nasdaq:NPCE) a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today...
NeuroPace to Participate in Upcoming Conferences
23. August 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Second Quarter 2021 Financial Results
12. August 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif. , Aug. 12, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
22. Juli 2021 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome
30. Juni 2021 08:00 ET
|
NeuroPace, Inc.
Feasibility IDE study will be the first to evaluate responsive neuromodulation for a severe and disabling childhood-onset epilepsy MOUNTAIN VIEW, Calif., June 30, 2021 (GLOBE NEWSWIRE) --...